A13:B7-24-GG
A13:B7-24-GG is an engineered analogue of insulin-like peptide 5 (INSL5), a selective RXFP4 agonist with a Ki value of 2.29 nM. A13:B7-24-GG has an extremely low binding affinity for RXFP3 (Ki = 602.56 nM) and an inhibitory effect on cAMP (EC50) of 1.17 nM. Activation of RXFP4 by A13:B7-24-GG leads to the recruitment of β-Arrestin2, with an EC50 of 22.39 nM. A13:B7-24-GG can be used for research on chronic constipation.
Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.
- CAS. Nr.: 3057097-31-8
- Formel: C149H236N40O47S5
- Molecular Weight:3500.03
-
Speicherung:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biologische Aktivität
Beschreibung
Chemical Information
-
CAS. Nr. 3057097-31-8
-
Molecular Weight 3500.03
-
Formel C149H236N40O47S5
-
Sequence
Chain1:Cys-Thr-Asp-Gly-Ala-Ser-Met-Lys-Asp-Leu-Ser-Ala-Leu-Cys Chain2:Cys-Gly-Leu-Glu-Tyr-Ile-Arg-Thr-Val-Ile-Tyr-Ile-Cys-Gly-Gly-Ser-Arg-Trp (Disulfidebridge:Chain 1 Cys1-Chain 2 Cys1, Chain 1 Cys14-Chain 2 Cys13)
-
Sequence Shortening
CTDGASMKDLSALC CGLEYIRTVIYICGGSRW (Disulfidebridge:Chain 1 Cys1-Chain 2 Cys1, Chain 1 Cys14-Chain 2 Cys13)
-
Versand
Room temperature in continental US; may vary elsewhere.
-
Speicherung
Please store the product under the recommended conditions in the Certificate of Analysis.
Reinheit & Dokumentation
Verweise
Calculators
Konzentration (Stammlösung) × Volumen (Stammlösung) = Konzentration (Ziellösung) × Volumen (Ziellösung)